{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:34:18Z","timestamp":1783535658167,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.hrthm.2006.05.010","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T15:15:52Z","timestamp":1147274152000},"page":"881-886","source":"Crossref","is-referenced-by-count":114,"title":["Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction"],"prefix":"10.1016","volume":"3","author":[{"given":"Ibrahim R.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Heeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"King-Hageman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Samuel C.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Beshai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Langberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2006.05.010_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib2","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","article-title":"Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation","volume":"104","author":"Mihm","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib5","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2143\/AC.56.6.2005701","article-title":"C-reactive protein and paroxysmal atrial fibrillation","volume":"56","author":"Dernellis","year":"2001","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/hrt.2004.038661","article-title":"C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion","volume":"91","author":"Wazni","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2006.05.010_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2004.12.041","article-title":"Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation","volume":"102","author":"Korantzopoulos","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jtcvs.2004.09.014","article-title":"The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery","volume":"130","author":"Prasongsukarn","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hrthm.2006.05.010_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cardiores.2004.01.018","article-title":"The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model","volume":"62","author":"Kumagai","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000145163.56529.D1","article-title":"Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs","volume":"110","author":"Shiroshita-Takeshita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.amjcard.2003.08.023","article-title":"Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion","volume":"92","author":"Siu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.amjcard.2003.08.040","article-title":"Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease","volume":"92","author":"Young-Xu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2003.11.004","article-title":"PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats","volume":"36","author":"Diep","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib15","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2003-11-3791","article-title":"Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro","volume":"103","author":"Kleemann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hrthm.2006.05.010_bib16","doi-asserted-by":"crossref","first-page":"48051","DOI":"10.1074\/jbc.M206966200","article-title":"Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice","volume":"277","author":"Duez","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2006.05.010_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2006.05.010_bib18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.271.11.840","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort","volume":"271","author":"Benjamin","year":"1994","journal-title":"Jama"},{"key":"10.1016\/j.hrthm.2006.05.010_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jacc.2005.11.068","article-title":"The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction","volume":"47","author":"Hanna","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib20","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.0000080895.05158.8B","article-title":"Statins promote potent systemic antioxidant effects through specific inflammatory pathways","volume":"108","author":"Shishehbor","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.RES.0000028004.76218.B8","article-title":"Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice","volume":"91","author":"Vecchione","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1254\/jphs.93.87","article-title":"Pravastatin prevents arrhythmias induced by coronary artery ischemia\/reperfusion in anesthetized normocholesterolemic rats","volume":"93","author":"Chen","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.hrthm.2006.05.010_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1152\/japplphysiol.00265.2003","article-title":"Statin therapy restores sympathovagal balance in experimental heart failure","volume":"95","author":"Pliquett","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9149(03)00643-X","article-title":"Effect of atorvastatin and fenofibrate on autonomic tone in subjects with combined hyperlipidemia","volume":"92","author":"Melenovsky","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.RES.0000195844.31466.e9","article-title":"Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels","volume":"97","author":"Fukuda","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.0000186804.96482.78","article-title":"Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function","volume":"97","author":"Wolin","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1527-5299.2002.00717.x","article-title":"Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure","volume":"8","author":"Sorescu","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.hrthm.2006.05.010_bib32","series-title":"Atherosclerosis","article-title":"Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages","author":"Veillard","year":"2005"},{"key":"10.1016\/j.hrthm.2006.05.010_bib33","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M505268200","article-title":"Mechanisms of statin-mediated inhibition of small G-protein function","volume":"280","author":"Cordle","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2006.05.010_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hrthm.2006.05.010_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","article-title":"Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway","volume":"98","author":"Paumelle","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.05.010_bib36","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.05.010_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.164.1.55","article-title":"National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation","volume":"164","author":"Fang","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2006.05.010_bib38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/archinte.159.14.1574","article-title":"Temporal trends in the use of anticoagulants among older adults with atrial fibrillation","volume":"159","author":"Smith","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2006.05.010_bib39","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.amjcard.2003.12.009","article-title":"Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion","volume":"93","author":"Tveit","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106014937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106014937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T15:56:43Z","timestamp":1547654203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527106014937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1547527106014937"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2006.05.010","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}